Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma.
Okamoto A, Fujigaki H, Iriyama C, Goto N, Yamamoto H, Mihara K, Inaguma Y, Miura Y, Furukawa K, Yamamoto Y, Akatsuka Y, Kasahara S, Miyao K, Tokuda M, Sato S, Mizutani Y, Osawa M, Hattori K, Iba S, Kajiya R, Okamoto M, Saito K, Tomita A. Okamoto A, et al. Among authors: inaguma y. Blood Adv. 2022 Jun 14;6(11):3230-3233. doi: 10.1182/bloodadvances.2021006302. Blood Adv. 2022. PMID: 35026843 Free PMC article. No abstract available.
Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy.
Okamoto A, Abe A, Okamoto M, Kobayashi T, Terazawa T, Inaguma Y, Tokuda M, Yanada M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Akatsuka Y, Mizuta S, Yoshikawa T, Emi N. Okamoto A, et al. Among authors: inaguma y. Int J Hematol. 2012 Oct;96(4):516-20. doi: 10.1007/s12185-012-1160-4. Epub 2012 Aug 18. Int J Hematol. 2012. PMID: 22903849
Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience.
Okamoto A, Yanada M, Inaguma Y, Tokuda M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Akatsuka Y, Mizuta S, Okamoto M, Emi N. Okamoto A, et al. Among authors: inaguma y. Hematology. 2013 Mar;18(2):74-80. doi: 10.1179/1607845412Y.0000000045. Epub 2012 Nov 19. Hematology. 2013. PMID: 23320957 Free article.
Construction and molecular characterization of a T-cell receptor-like antibody and CAR-T cells specific for minor histocompatibility antigen HA-1H.
Inaguma Y, Akahori Y, Murayama Y, Shiraishi K, Tsuzuki-Iba S, Endoh A, Tsujikawa J, Demachi-Okamura A, Hiramatsu K, Saji H, Yamamoto Y, Yamamoto N, Nishimura Y, Takahashi T, Kuzushima K, Emi N, Akatsuka Y. Inaguma Y, et al. Gene Ther. 2014 Jun;21(6):575-84. doi: 10.1038/gt.2014.30. Epub 2014 Apr 3. Gene Ther. 2014. PMID: 24694533
A varicella outbreak in B-cell lymphoma patients receiving rituximab-containing chemotherapy.
Okamoto A, Abe A, Okamoto M, Kobayashi T, Inaguma Y, Tokuda M, Yanada M, Morishima S, Kanie T, Yamamoto Y, Tsuzuki M, Mizuta S, Akatsuka Y, Yatsuya H, Yoshikawa T, Emi N. Okamoto A, et al. Among authors: inaguma y. J Infect Chemother. 2014 Dec;20(12):774-7. doi: 10.1016/j.jiac.2014.08.006. Epub 2014 Aug 30. J Infect Chemother. 2014. PMID: 25179391
Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.
Inaguma Y, Akatsuka Y, Hosokawa K, Maruyama H, Okamoto A, Katagiri T, Shiraishi K, Murayama Y, Tsuzuki-Iba S, Mizutani Y, Nishii C, Yamamoto N, Demachi-Okamura A, Kuzushima K, Ogawa S, Emi N, Nakao S. Inaguma Y, et al. Br J Haematol. 2016 Jan;172(1):131-4. doi: 10.1111/bjh.13464. Epub 2015 Apr 30. Br J Haematol. 2016. PMID: 25929998 Free article. No abstract available.
153 results